Advertisement

Pharmaceutical Chemistry Journal

, Volume 9, Issue 11, pp 688–691 | Cite as

Synthesis and pharmacological activity of phenothiazine derivatives containing the adamantyl radical

  • N. V. Klimova
  • L. N. Lavrova
  • G. V. Pushkar'
  • M. I. Shmar'yan
  • A. P. Arendaruk
  • A. P. Skoldinov
Search for New Drugs

Keywords

Organic Chemistry Pharmacological Activity Phenothiazine Adamantyl Phenothiazine Derivative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    K. Gerzon, E. V. Krumkalns, R. L. Brindle, et al., “The adamantyl group in medicinal agents. I. Hypoglycemic N-arylsulfonyl-N-adamantyl ureas,” J. Med. Chem.,6, 760–763 (1963).Google Scholar
  2. 2.
    Farbwerke Hoechst, A.-G., “Phenylsulfonyl urea compounds,” Chem. Abstracts,68, 49301 (1968).Google Scholar
  3. 3.
    A. P. Arendaruk et al., “Curare-like action of monoquaternary salts containing the adamantyl group on a nitrogen atom,” Khim.-Farm. Zh., No. 4, 8–13 (1972).Google Scholar
  4. 4.
    A. P. Arendaruk et al., “Synthesis and pharmacological properties of bisquaternary salts of α-ω-di-[N-methyl-N-(1-adamantyl)amino]alkanes,” ibid., No. 5, 11–14 (1972).Google Scholar
  5. 5.
    A. P. Arendaruk et al., “Synthesis and pharmacological properties of the bis-methiodide of bis-[β-(N-methyl-N-1-adamantyl)aminoethyl] succinate (diadonium),” ibid., No. 8, 8–11 (1972).Google Scholar
  6. 6.
    R. Rapala, J. Kraay, and K. Gerzon, “The adamantyl group in medicinal agents. II. Anabolic steroid 17β-adamantoates,” J. Med. Chem.,8, 580–583 (1965).Google Scholar
  7. 7.
    S. N. Pandeya, “Biological activity of adamantyl derivatives,” Indian J. Pharm.,33, 1–9 (1971).Google Scholar
  8. 8.
    M. D. Mashkovskii, S. S. Liberman, and A. I. Polezhaeva, “The pharmacology of aminazin,” Farmakol. i Toksikol., No. 1, 14–22 (1955).Google Scholar
  9. 9.
    Yu. I. Vikhlyaev and N. V. Kaverina, “Effect of a new series of phenothiazine derivatives on some forms of experimental arrhythmia,” in; New Data on the Pharmacology and Clinics of Compounds of the Phenothiazine Series [in Russian], Moscow (1958), pp. 97–103.Google Scholar
  10. 10.
    H. Rosenkilde and W. M. Govier, “A comparison of some phenothiazine derivatives in inhibiting apomorphine-induced emesis,” J. Pharmacol. Exp. Ther.,120, 375–378 (1957).Google Scholar
  11. 11.
    A. N. Gritsenko et al., “Syntheses in the phenothiazine series. XXXI. 10-γ-Alkylamino derivatives and 10-β-alkylamino derivatives of substituted phenothiazines,” Khim.-Farm, Zh., No. 7, 10–14 (1971).Google Scholar

Copyright information

© Plenum Publishing Corporation 1976

Authors and Affiliations

  • N. V. Klimova
    • 1
  • L. N. Lavrova
    • 1
  • G. V. Pushkar'
    • 1
  • M. I. Shmar'yan
    • 1
  • A. P. Arendaruk
    • 1
  • A. P. Skoldinov
    • 1
  1. 1.Institute of PharmacologyAcademy of Medical Sciences of the USSRMoscow

Personalised recommendations